CRISPR治疗（CRSP.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

机构投资者80.16%
公众及其他19.41%
个人与内部人士0.43%

主要股东

主要股东最新
股东
ARK Investment Management LLC	11.70%	1,131.36 万	0.73%	+79.16 万	2026/03/31
BlackRock, Inc.	8.63%	834.90 万	0.67%	+66.89 万	2026/06/30
Capital Research and Management Company	6.43%	622.15 万	0.09%	+10.53 万	2026/06/30
Orbis Investment Management Limited	6.31%	610.60 万	0.11%	+15.59 万	2026/03/31
State Street Investment Management	4.47%	432.17 万	0.34%	+33.92 万	2026/06/30
GSK Equity Investments, Limited	3.33%	322.06 万	0.01%	+0	2026/06/30
T. Rowe Price Group, Inc.	3.16%	305.76 万	0.29%	-25.39 万	2026/03/31
Geode Capital Management, LLC	2.60%	250.99 万	0.13%	+13.28 万	2026/06/30
SR One Capital Management, LP	2.11%	203.88 万	<0.01%	+0	2026/06/30
FMR LLC	1.97%	190.40 万	0.05%	-4.66 万	2026/06/30
Vanguard Capital Management, LLC	1.81%	175.19 万	0.06%	+6.67 万	2026/06/30
Amova Asset Management Co., Ltd.	1.78%	172.07 万	0.14%	-13.31 万	2026/06/30
Two Sigma Investments, LP	1.53%	148.31 万	1.04%	+101.24 万	2026/03/31
EcoR1 Capital, LLC	1.44%	138.93 万	0.01%	+0	2026/03/31
UBS Asset Management AG	1.36%	131.87 万	0.63%	-60.12 万	2026/06/30
New Enterprise Associates, Inc.	1.09%	105.86 万	<0.01%	+0	2026/03/31
Charles Schwab Investment Management, Inc.	1.07%	103.93 万	<0.01%	+0	2026/06/30
Loomis, Sayles & Company, L.P.	1.00%	96.81 万	0.06%	+6.88 万	2026/03/31
Australian Super Pty Ltd	0.92%	89.12 万	<0.01%	+0	2025/12/31
Northern Trust Global Investments	0.89%	86.31 万	0.06%	+6.09 万	2026/06/30